Last reviewed · How we verify
NCT07188389: IMEX
Immunometabolism of Exercise
NA trial testing Acute exercise-moderate intensity in Cardiorespiratory Fitness and Acute Exercise in 102 participants. Completed in 3 April 2025.
2 April 2025
Quick facts
| Lead sponsor | University of Houston |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 102 |
| Start date | 1 March 2024 |
| Primary completion | 2 April 2025 |
| Estimated completion | 3 April 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Acute exercise-moderate intensity
- Acute effects-heavy intensity
Conditions studied
- Cardiorespiratory Fitness and Acute Exercise — all drugs for Cardiorespiratory Fitness and Acute Exercise →
Sponsor
University of Houston
Who can join
Adults 20 to 40, any sex, with Cardiorespiratory Fitness and Acute Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to examine the effects of acute aerobic exercise and cardiorespiratory fitness on cellular metabolism of CD8+ T cells and regulatory T cells (Tregs) found in the peripheral blood of humans. In addition, the study will investigate whether the effects of exercise differ based on exercise intensity, as well as whether the effects of exercise and fitness differ between subpopulations of CD8+ T cells and Tregs. Finally, the study aims to examine whether exercise- and fitness-induced changes in cell metabolism relate to changes in cell function.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07188389
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Houston trials
Trials by the same sponsor.
- NCT07024992 — Enhancing Smoking Cessation for African American People Everywhere · Phase 2 · not yet recruiting
- NCT07025772 — Shaping Habitual Impulses For a Tobacco-free Style · NA · recruiting
- NCT07007195 — Smart Olfaction App to Reduce Relapse · EARLY_PHASE1 · not yet recruiting
- NCT06918821 — Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study · NA · recruiting
- NCT07227220 — Summer Youth Employment Programs for Health Promotion · EARLY_PHASE1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07188389 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Houston
- Last refreshed: 23 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07188389.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing